Results 131 to 140 of about 9,247 (168)

Serine Protease HTRA1 Membranous Nephropathy With Polytypic IgG Concurrent With Plasma Cell Dyscrasia. [PDF]

Kidney Med
Zuckerman JE, Larson S, Abdelnour L.
europepmc   +1 more source

Acute kidney injury with interstitial hemorrhage in renal heavy chain amyloidosis: a clinicopathologic case report. [PDF]

CEN Case Rep
Mori N, Maeda K, Ito R, Handa Y, Tagawa H, Onagi S, Kametani F, Yazaki M, Isaki T, Kropp A, Kakizaki Y, Yamazaki M, Watanabe T.   +12 more
europepmc   +1 more source

Infection risks associated with daratumumab-containing regimens in multiple myeloma: a systematic review and meta-analysis. [PDF]

Front Oncol
Huang ZY, Liu XL, Li T, Luo CH.
europepmc   +1 more source

Addressing unmet needs in relapsed/refractory multiple myeloma: an Italian Delphi consensus on current challenges and emerging therapies. [PDF]

Front Oncol
Cavo M, Bringhen S, Buda G, Di Raimondo F, Musto P, Offidani M, Petrucci MT, Zamagni E, Zambello R, Berruto F, Freddi R, La Malfa P.   +11 more
europepmc   +1 more source

Daratumumab-based salvage therapy enables umbilical cord blood transplantation in multiline refractory, elderly T-lymphoblastic lymphoma: a case report. [PDF]

Front Immunol
Yang Q, Yang L, Cai P, Ji YH, Zhou JD, Qian J.   +5 more
europepmc   +1 more source

Treatment with Daratumumab in Combination with Glucocorticosteroids as First-Line Treatment Achieves a Complete Remission for a Patient with Multiple Myeloma and Resolves Neutropenia: A Case Report. [PDF]

Case Rep Oncol
Mettias S, Cheung J, Moore J, Berenson JR.   +3 more
europepmc   +1 more source

Smoldering multiple myeloma in transition: redefining early myeloma in the modern era. [PDF]

Leukemia
Landgren O.
europepmc   +1 more source

Daratumumab in systemic lupus erythematosus: a single-arm phase 2 trial. [PDF]

Nat Commun
Ostendorf L, Zernicke J, Klotsche J, Kempkens R, Beenken AE, Biesen R, Cheng Q, Khodadadi L, Guerra GM, Heinrich F, Durek P, Burmester GR, Krönke G, Hiepe F, Mashreghi MF, Alexander T.   +15 more
europepmc   +1 more source

Talquetamab: Mechanism of Action, Clinical, and Translational Science. [PDF]

Clin Transl Sci
Wang Y, Gong J, Au N, Zhou J, Yuan D, Tolbert J, Zhang G, Vishwamitra D, Zhang J, Haddish-Berhane N, Singh I.   +10 more
europepmc   +1 more source

Resolving the Interference of Anti-CD38 Antibodies on Blood Compatibility Assays Using CD38 "Baitbodies" Approach. [PDF]

J Immunol Res
Gnann DC, Steinke S, Garritsen HSP, Hust M.   +3 more
europepmc   +1 more source